Karyopharm Therapeutics Inc. (KPTI)
MA
Total Compensation for Fiscal Year Ending in 2022: $6,910,015
Salary | $696,800 |
---|---|
Bonus | $200,000 |
Value of Stock Awards | $2,982,788 |
Value of Option Awards | $2,562,984 |
Non-Equity Incentive Plan Compensation | $452,920 |
Change in Pension Value and Deferred Compensation Earnings | $0 |
All Other Compensation | $14,523 |
Total | $6,910,015 |
Karyopharm Therapeutics Inc. disclosed its CEO pay was
31
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?